Eliud Wandwalo, Management Sciences for Health Claire Moodie, Management Sciences for Health Yared Kebede Haile, KNCV Tuberculosis Foundation Amos Kutwa, KNCV Tuberculosis Foundation Odile Ferroussier, Union internationale contre la tuberculose et les maladies respiratoires Chawalit Natpratan, Family Health International
1
Elizabeth Glaser Pediatric AIDS Foundation
1
Elizabeth Glaser Pediatric AIDS Foundation
1
Elizabeth Glaser Pediatric New Horizons (Advancing Pediatric HIV Care)
1
Elizabeth Lamond, and Jesee Kinyanjui
1
Elke Müllegger, Günter Langergraber, and Markus Lechner
1
Elly T. Katabira,Moses R. Kamya, Israel Kalyesubula, Alice Namale
1
ELRHA
1
Elvis E. Tarkang, Prosper M. Lutala
1
Emergency Operations and Emergency Response Team
1
Emily Keane, Andrea King, Anthony Awira et al.
1
Emma Mbalame
1
EMTCT Global Validation Advisory Committee, Global HIV, Hepatitis and Sexually Transmitted Infections Programmes
1
ENAP Ebola Needs Analaysis Project
1
End Polio Pakistan
1
Engender Health, ICW
1
EngenderHealt;
1
Environment International
1
Environmental Research Letters
1
Environmentally Sustainable Development supported by World Bank
WHO/HTM/TB/2007.384a
“TB is too often a death sentence for people with AIDS.
It does not have to be this way.”
-Nelson Mandela, International conference on HIV /AIDS, Bangkok, Thailand, July 2004
E. A. CooremanWHO SEARODepartment of Control of Neglected Tropical Diseases
(2017)
C_WHO
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf...ections. Clofazimine resistance is still rare but this antimicrobial cannot be given alonemore